166 related articles for article (PubMed ID: 35449124)
21. MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2.
Ai L; Luo X; Yan X; Jiang S
Bioengineered; 2021 Dec; 12(1):4044-4053. PubMed ID: 34288823
[TBL] [Abstract][Full Text] [Related]
22. Hotair mediates tumorigenesis through recruiting EZH2 in colorectal cancer.
Huang KB; Zhang SP; Zhu YJ; Guo CH; Yang M; Liu J; Xia LG; Zhang JF
J Cell Biochem; 2019 Apr; 120(4):6071-6077. PubMed ID: 30362162
[TBL] [Abstract][Full Text] [Related]
23. Enhancer of zeste homolog 2 contributes to apoptosis by inactivating janus kinase 2/ signal transducer and activator of transcription signaling in inflammatory bowel disease.
Zhou J; Yang Y; Wang YL; Zhao Y; Ye WJ; Deng SY; Lang JY; Lu S
World J Gastroenterol; 2021 Jun; 27(22):3073-3084. PubMed ID: 34168409
[TBL] [Abstract][Full Text] [Related]
24. EZH2 depletion blocks the proliferation of colon cancer cells.
Fussbroich B; Wagener N; Macher-Goeppinger S; Benner A; Fälth M; Sültmann H; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
PLoS One; 2011; 6(7):e21651. PubMed ID: 21765901
[TBL] [Abstract][Full Text] [Related]
25. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
26. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
[TBL] [Abstract][Full Text] [Related]
27. EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment.
Li C; Song J; Guo Z; Gong Y; Zhang T; Huang J; Cheng R; Yu X; Li Y; Chen L; Ma X; Sun Y; Wang Y; Xue L
Front Immunol; 2022; 13():857808. PubMed ID: 35432300
[TBL] [Abstract][Full Text] [Related]
28. Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis.
Yu J; Li S; Guo J; Xu Z; Zheng J; Sun X
Cell Death Dis; 2020 Aug; 11(8):640. PubMed ID: 32807788
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7.
Di W; Weinan X; Xin L; Zhiwei Y; Xinyue G; Jinxue T; Mingqi L
Cell Death Dis; 2019 Jul; 10(7):514. PubMed ID: 31273190
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro.
He SB; Zhou H; Zhou J; Zhou GQ; Han T; Wan DW; Gu W; Gao L; Zhang Y; Xue XF; Zhang LF; Fei M; Hu SQ; Yang XD; Zhu XG; Wang L; Li DC
Exp Biol Med (Maywood); 2015 Apr; 240(4):458-66. PubMed ID: 25005166
[TBL] [Abstract][Full Text] [Related]
31. Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.
Ma L; Lin K; Chang G; Chen Y; Yue C; Guo Q; Zhang S; Jia Z; Huang TT; Zhou A; Huang S
Cancer Res; 2019 Jan; 79(1):72-85. PubMed ID: 30425057
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer.
Bai Y; Zhang Z; Cheng L; Wang R; Chen X; Kong Y; Feng F; Ahmad N; Li L; Liu X
J Biol Chem; 2019 Jun; 294(25):9911-9923. PubMed ID: 31085587
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.
Oki S; Sone K; Oda K; Hamamoto R; Ikemura M; Maeda D; Takeuchi M; Tanikawa M; Mori-Uchino M; Nagasaka K; Miyasaka A; Kashiyama T; Ikeda Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Kawana K; Fukayama M; Osuga Y; Fujii T
Oncotarget; 2017 Jun; 8(25):40402-40411. PubMed ID: 28418882
[TBL] [Abstract][Full Text] [Related]
34. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract][Full Text] [Related]
35. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1.
Liang W; Wu J; Qiu X
J Transl Med; 2021 Jan; 19(1):45. PubMed ID: 33499872
[TBL] [Abstract][Full Text] [Related]
36. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
37. (-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells.
Ying L; Yan F; Williams BR; Xu P; Li X; Zhao Y; Hu Y; Wang Y; Xu D; Dai J
Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):58-67. PubMed ID: 28925507
[TBL] [Abstract][Full Text] [Related]
38. LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1.
Qin J; Li Y; Li Z; Qin X; Zhou X; Zhang H; Li S
Clin Epigenetics; 2022 Apr; 14(1):51. PubMed ID: 35414117
[TBL] [Abstract][Full Text] [Related]
39. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
40. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
